St George's, University of London-ko ikertzaileekin lankidetzan egindako argitalpenak (45)

2024

  1. Magnitude and determinants of excess total, age-specific and sex-specific all-cause mortality in 24 countries worldwide during 2020 and 2021: results on the impact of the COVID-19 pandemic from the CMOR project

    BMJ Global Health, Vol. 9, Núm. 4

2023

  1. Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial

    International Journal of Cardiology, Vol. 391

  2. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

    Clinical Research in Cardiology, Vol. 112, Núm. 6, pp. 759-771

2022

  1. Excess all-cause mortality and COVID-19-related mortality: a temporal analysis in 22 countries, from January until August 2020

    International Journal of Epidemiology, Vol. 51, Núm. 1, pp. 35-53

2021

  1. Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: Observational study using prospectively collected registry data

    BMJ, Vol. 375

  2. Editorial: The EXCEL trial

    European Cardiology Review

  3. The ISCHEMIA trial: And the winner is… the patient

    European Cardiology Review

2019

  1. Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry

    Journal of the American Heart Association, Vol. 8, Núm. 3

  2. Safety and efficacy of dronedarone from clinical trials to real-world evidence: Implications for its use in atrial fibrillation

    Europace, Vol. 21, Núm. 12, pp. 1764-1775

2018

  1. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835

2016

  1. Shared genetic contribution to ischemic stroke and Alzheimer's disease

    Annals of Neurology, Vol. 79, Núm. 5, pp. 739-747

2015

  1. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation

    Circulation: Cardiovascular Quality and Outcomes, Vol. 8, pp. S12-S20

  2. Pharmacological treatment of chronic stable angina pectoris

    Springer International Publishing, pp. 1-278

2014

  1. Birthweight and the risk of atopic diseases: The ISAAC Phase III study

    Pediatric Allergy and Immunology, Vol. 25, Núm. 3, pp. 264-270

2012

  1. Cardiopulmonary exercise testing for the assessment of exercise capacity in patients with cardiac syndrome X

    International Journal of Cardiology, Vol. 154, Núm. 1, pp. 85-87

  2. Valor pronóstico del intervalo QT corregido y su correlación con la troponina T cardíaca en el síndrome coronario agudo sin elevación del segmento ST

    Revista Argentina de Cardiologia, Vol. 80, Núm. 6, pp. 439-445

2010

  1. Elevated circulating soluble form of CD40 ligand in patients with cardiac syndrome X

    Atherosclerosis, Vol. 213, Núm. 2, pp. 637-641

  2. Neopterin - Marker of coronary artery disease activity or extension in patients with chronic stable angina?

    International Journal of Cardiology, Vol. 144, Núm. 1, pp. 74-75

  3. Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

    Atherosclerosis, Vol. 211, Núm. 2, pp. 574-578

  4. Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with st-segment elevation myocardial infarction

    American Journal of Cardiology, Vol. 106, Núm. 11, pp. 1540-1544